Clinical Trial

Inositol in Letrozol Resistant PCOS Women

Completed Phase 2/3
View on ClinicalTrials.gov →
Summary
Polycystic ovary syndrome (PCOS),is a complex neuro-endocrine disorder affecting approximately 5% to 10% of women in reproductive age.Inositols are considered insulin sensitizers, as they modulate the members of insulin signaling pathways.Thiss study compares between the effect of inositol and metformin in letrozol resistant PCOS women.
Protocol Amendment History 3 changes
critical Trial status changed: Not Yet Recruiting → Completed 2026-05-19
notable Primary completion moved earlier: 2027-05-14 -> 2026-05-10 2026-05-19
minor Completion moved earlier: 2027-09-14 -> 2026-05-11 2026-05-19
Trial Details
NCT Number NCT07585396
Lead Sponsor Kafrelsheikh University
Conditions Polycystic Ovary Syndrome, Infertility
Enrollment 136 participants
Start Date 2024-04-10
Primary Completion 2026-06-10 (estimated)
Study Completion 2026-07-11 (estimated)
Updated on ClinicalTrials.gov 2026-07-29